Outcome of Board Meeting held on Thursday, August 28, 2025

Results View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+2.0%Reaction day

₹290.70

prior close

₹296.50

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.7%+2.7% vs market

Medical Equipment & Supplies peers, median of 12sector-2.3%+4.3% vs sector

On the reaction day the stock moved 2.7 pts more than Nifty Microcap 250 and 4.3 pts more than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.0

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+2.0-0.7+2.7-2.3+4.3

Next day

+0.4-0.9+1.3-0.2+0.7

+2.4+0.4+2.0+0.1+2.3

+3.8+1.3+2.6-0.4+4.2

+3.8+2.3+1.6+1.2+2.6

+3.9+1.6+2.3+1.1+2.8

+8.1+2.0+6.0-2.3+10.4

15d

+26.3+4.2+22.1+0.2+26.0

+9.7-1.0+10.6-4.5+14.2

-3.4+2.6-6.0-7.2+3.8

-10.6-0.4-10.2-17.9+7.3

UpDownMarket · Nifty Microcap 250Sector · Medical Equipment & Supplies peers, median of 12Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The board of Hemant Surgical Industries approved the Directors' Report and Management Discussion & Analysis for FY ended March 31, 2025, and fixed September 23, 2025 as the date for the 36th Annual General Meeting. It appointed M/s. ADMS and Company as Internal Auditor, M/s. NKM and Associates as Secretarial Auditor, and M/s. K Sorathiya & Co as Cost Auditor, all for FY 2025-26. Mr. Manish Kankani (Chartered Accountant with 10 years' experience) was appointed as an Additional Non-Executive Independent Director for a 5-year term, subject to shareholder approval. The board also noted the resignation of Independent Director Mr. Ketan Chandrakant Dave, effective immediately, citing health reasons with no other material reasons disclosed.

Likely market impact

These are largely routine administrative and governance updates. The director change due to health reasons is minor, and the new auditors and independent director bring standard expertise. No material financial impact is expected from these disclosures.